Published in Medical Letter on the CDC and FDA, September 7th, 2003
FDA expedited review of the product, called the Independence iBOT 3000 Mobility System, because it represents a breakthrough technology with the potential to benefit people with disabilities. An estimated 2 million people in the United States use wheelchairs.
"This wheelchair represents a breakthrough in wheelchair technology," said FDA Commissioner Mark B. McClellan, MD, PhD. "It can help improve the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.